These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19878063)

  • 1. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
    Singh K; Srivastava A; Mathur N; Kumar S; Kumar L; Mukhopadhyay A; Konchupillai V
    Cytotherapy; 2009; 11(6):768-77. PubMed ID: 19878063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
    Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
    Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between peripheral blood and cord blood in the kinetics of lineage-restricted hematopoietic cells: implications for delayed platelet recovery following cord blood transplantation.
    Yasui K; Matsumoto K; Hirayama F; Tani Y; Nakano T
    Stem Cells; 2003; 21(2):143-51. PubMed ID: 12634410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
    Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
    J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
    Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
    Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary findings on the use of pulsatile machine reperfusion of a placenta to improve the cord blood collection yield including primitive hematopoietic stem cell fractions.
    Takebe N; Gage F; Cheng X; Lauw MI
    Transfusion; 2009 Sep; 49(9):1911-6. PubMed ID: 19497058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells.
    Takahashi M; Matsuoka Y; Sumide K; Nakatsuka R; Fujioka T; Kohno H; Sasaki Y; Matsui K; Asano H; Kaneko K; Sonoda Y
    Leukemia; 2014 Jun; 28(6):1308-15. PubMed ID: 24189293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection.
    Nagler A; Peacock M; Tantoco M; Lamons D; Okarma TB; Okrongly DA
    Exp Hematol; 1994 Nov; 22(12):1134-40. PubMed ID: 7523166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells.
    Lim CK; Sun L; Feng Q; Law P; Chua WT; Lim SN; Hwang WY
    J Hematol Oncol; 2008 Oct; 1():19. PubMed ID: 18947412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term culture and identification of CD133⁺ hematopoietic progenitor cells from human umbilical cord blood].
    Wu XJ; Chen F; Lu YX; Yang H; Peng FL; Yuan L; Liu GB; Li XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):349-53. PubMed ID: 22445981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells.
    Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM
    Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells.
    Kekarainen T; Mannelin S; Laine J; Jaatinen T
    BMC Cell Biol; 2006 Aug; 7():30. PubMed ID: 16882340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation.
    Payne TA; Traycoff CM; Laver J; Xu F; Srour EF; Abboud MR
    Bone Marrow Transplant; 1995 Feb; 15(2):187-92. PubMed ID: 7539665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential gene expression profiling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells.
    He X; Gonzalez V; Tsang A; Thompson J; Tsang TC; Harris DT
    Stem Cells Dev; 2005 Apr; 14(2):188-98. PubMed ID: 15910245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells.
    Bonanno G; Perillo A; Rutella S; De Ritis DG; Mariotti A; Marone M; Meoni F; Scambia G; Leone G; Mancuso S; Pierelli L
    Transfusion; 2004 Jul; 44(7):1087-97. PubMed ID: 15225252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133+ cell content does not influence recovery time after hematopoietic stem cell transplantation.
    Jaime-Pérez JC; Guillermo-Villanueva VA; Méndez-Ramírez N; Chapa-Rodríguez A; Gutiérrez-Aguirre H; Gómez-Almaguer D
    Transfusion; 2009 Nov; 49(11):2390-4. PubMed ID: 19903294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.